SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001477932-18-003157
Filing Date
2018-06-20
Accepted
2018-06-20 17:30:36
Documents
48

Document Format Files

Seq Description Document Type Size
1 POS AM oncx_posam.htm POS AM 1005572
2 LEGAL OPINION oncx_ex51.htm EX-5.1 4779
3 CONSENT oncx_ex231.htm EX-23.1 1274
10 oncx_posamimg1.jpg GRAPHIC 24368
  Complete submission text file 0001477932-18-003157.txt   3795117

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT oncx-20180331.xml EX-101.INS 602794
5 XBRL TAXONOMY EXTENSION SCHEMA oncx-20180331.xsd EX-101.SCH 44041
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oncx-20180331_cal.xml EX-101.CAL 29193
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oncx-20180331_def.xml EX-101.DEF 168772
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE oncx-20180331_lab.xml EX-101.LAB 232725
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oncx-20180331_pre.xml EX-101.PRE 213265
Mailing Address 14405 WALTERS ROAD SUITE 780 HOUSTON TX 77014
Business Address 14405 WALTERS ROAD SUITE 780 HOUSTON TX 77014 281-402-3167
Oncolix, Inc. (Filer) CIK: 0001584137 (see all company filings)

IRS No.: 463046340 | State of Incorp.: FL | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-222159 | Film No.: 18910276
SIC: 2834 Pharmaceutical Preparations